Sana Biotechnology Inc reports results for the quarter ended September 30 - Earnings Summary

Sana Biotechnology

08/11/2024 16:14

* Sana Biotechnology Inc  SANA.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of 2 cents.  The mean expectation of seven analysts for the
quarter was for a loss of 25 cents per share. Wall Street
expected results to range from -27 cents to -22 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sana Biotechnology Inc's reported EPS for the quarter was
a loss
of 25 cents​.
    * The company reported a quarterly loss of $59.92 million.
    * Sana Biotechnology Inc shares had fallen by 25.5% this
quarter and lost 24.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Sana
Biotechnology Inc is 10.00 
This summary was machine generated from LSEG data November 8 at
04:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.25          -0.25          Met
 Jun. 30 2024      -0.28          -0.21          Beat
 Mar. 31 2024      -0.32          -0.49          Missed
 Dec. 31 2023      -0.38          -0.41          Missed